Recall Register

Device recall: TRIGEN PROXIMAL STRAIGHT HUMERAL NAIL 8/7 X 16, REF: 71760816

Class II FDA enforcement event 98629. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Humeral nail due to a manufacturing error is missing distal holes and if implanted may lead to revision surgery but, if the missing holes are identified before implantation, an equivalent backup can be used, or a bent nail of the same size, which would require additional surgical steps to address soft tissue/bone preparation, which could lead to a surgical delay of greater than 30 minutes.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Smith & Nephew, Inc. started this device recall on 16 Mar 2026. The firm address in the FDA record is in Memphis, TN. FDA put the recall in Class II. FDA event 98629 has 1 product record. The first FDA enforcement report date is 24 Jun 2026. The record gives the status Ongoing.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

International distribution to the countries of BE, DE, IT.

Recalling firm

Smith & Nephew, Inc., Memphis, TN.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 98629: product records
Recall numberProductQuantityClassStatusReport date
Z-2456-2026TRIGEN PROXIMAL STRAIGHT HUMERAL NAIL 8/7 X 16, REF: 717608165Class IIOngoing24 Jun 2026

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2026
572
Share of these events in Class II
87%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
107

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 98629. https://recallregister.com/fda/ii/98629/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: International distribution to the countries of BE, DE, IT.
What quantity of product is in FDA event 98629?
The FDA record gives this quantity: 5
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2026 have the same class?
87% of the 572 device events that started in 2026 are in Class II.